Henrik Fagman

5PUBLICATIONS
45CO-AUTHORS
Predictive and prognostic markersMolecular targetsMechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 11, 2026
PIK3CA mutation testing and alpelisib use in metastatic breast cancer: a real-world data set.

|Sep 11, 2025
The levels of circulating tumor DNA and inflammatory proteins depict the clinical response in a patient with metastatic undifferentiated pleomorphic sarcoma, a case report.

Christoffer Vannas, Mandy Escobar, Margaréta Tanyasiová

|Aug 23, 2024
Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis.

Torben Ek, Raghda R Ibrahim, Hartmut Vogt

|Aug 11, 2021
Tissue architecture delineates field cancerization in BRAFV600E-induced tumor development.

Elin Schoultz, Ellen Johansson, Carmen Moccia

|Apr 06, 2021
Discovery of a rare GKAP1-NTRK2 fusion in a pediatric low-grade glioma, leading to targeted treatment with TRK-inhibitor larotrectinib.

Lily Deland, Simon Keane, Thomas Olsson Bontell

Pageof 1

Frequent Collaborators

3 joint publications

Christoffer Vannas

2 joint publications

Martin Dalin

2 joint publications

Anders Ståhlberg

2 joint publications

Tobias Österlund